Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) Starts Presentation at LD Micro Main Event
Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives, cancer care and unique prescription products that use innovative, patented or proprietary formulations of previously-approved active pharmaceutical ingredients. Citius seeks to achieve leading market positions by providing therapeutic products that address unmet medical needs by using previously approved drugs with substantial safety and efficacy data. Citius develops products that have intellectual property protection and competitive advantages to existing therapeutic approaches. For more information, visit the company’s website at www.citiuspharma.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information…







